Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Arrowhead Research acquires targeted drug delivery company Alvos Therapeutics

Executive Summary

Arrowhead Research Corp. (nanomedicines for cancer, obesity, and related metabolic and liver disorders) has acquired privately owned cancer drug discovery company Alvos Therapeutics Inc. (formerly Mercator Therapeutics). Arrowhead issued 315k of its common shares up front (valued at about $2mm) and could issue another $23.5mm in stock earn-outs based on clinical and regulatory achievements, plus additional sales-based earn-outs for the first three drugs developed.

Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
      • Site Specific
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Full Acquisition
    • Includes Earnout
    • Intra-Biotech Deal
    • Payment Includes Stock

Related Companies